Pharmaceutical Raw Materials Manufacturing in China
| Publication Date | March 2008 |
|---|---|
| Publisher | IBISWorld |
| Product Type | Report |
| Pages | 46 |
| ISBN Number | not applicable |
| Product Code | IBI01570 |
Summary
The IBISWorld Pharmaceutical Raw Materials Manufacturing in China industry report is comprised of establishments primarily engaged in the manufacture of chemical medicine raw materials for further manufacture of finished pharmaceutical products. This industry is within the Chemical Pharmaceutical Manufacturing sub-sector in China, which includes the manufacture of chemical substances for pharmacy, such as bacteriophage, endocrine products, basic vitamins, sulfanilamide medicine, salicylate, glucose and alkaloids. However, hematic products are not included. This industry acts as a bridge between the upstream chemical industry and the downstream medical market, and is affected not only by the economy and trade, but also by medical insurance levels of China.
Content
- Industry Definition
- Activities (Products and Services)
- Similar Industries
- Other Related Industries
- Key Statistics
- Current Prices
- Constant Prices
- Real Growth
- Ratio Table
- Segmentation
- Products and Service Segmentation
- Major Market Segments
- Industry Concentration
- Geographic Spread
- Market Characteristics
- Market Size
- Linkages
- Demand Determinants
- Domestic and International Markets
- Basis of Competition
- Life Cycle
- Industry Conditions
- Barriers to Entry
- Taxation
- Industry Assistance
- Regulation and Deregulation
- Cost Structure
- Capital and Labor Intensity
- Technology and Systems
- Industry Volatility
- Globalization
- Key Factors
- Key Sensitivities
- Key Success Factors
- Key Competitors
- Major Players
- Player Performance
- Other Players
- Industry Performance
- Current Performance
- Historical Performance
- Outlook
About this Product
Delivery Details
PDF:Immediate delivery
Related Products
Recently Viewed Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















